✦ LIBER ✦

CAN MRI IMPROVE THE PREDICTIVE ABILITY OF BIOPSY IN SELECTING MEN FOR UNILATERAL HEMIABLATIVE FOCAL THERAPY?

✍ Scribed by Tareen, Basir; Ito, Timothy; Godoy, Guilherme; Taouli, Bachir; Taneja, Samir S

Book ID: 122878252
Publisher: Lippincott Williams and Wilkins
Year: 2009
Tongue: English
Weight: 57 KB
Volume: 181
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(09)60504-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

195 NEGATIVE RESULT IN UNILATERAL 13-COR

195 NEGATIVE RESULT IN UNILATERAL 13-CORE BIOPSY CAN PREDICT THE ABSENCE OF SIGNIFICANT CANCER ON THE IPSILATERAL LOBE WITH A HIGH ACCURACY. IMPLICATIONS FOR HEMIABLATIVE FOCAL THERAPY

✍ Numao, Noboru; Kawakami, Satoru; Saito, Kazutaka; Sakura, Mizuaki; Yoshida, Soic 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 66 KB

357 Can MRI improve selection of patient

357 Can MRI improve selection of patients eligible for focal therapy in localized prostate cancer?

✍ Berg, R-E.; Rud, E.; Klotz, D.; Lundeby, E.; Rennesund, K.; Diep, L.M.; Baco, E. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Combination of Diffusion-weighted Magnet

Combination of Diffusion-weighted Magnetic Resonance Imaging and Extended Prostate Biopsy Predicts Lobes Without Significant Cancer: Application in Patient Selection for Hemiablative Focal Therapy

✍ Matsuoka, Yoh; Numao, Noboru; Saito, Kazutaka; Tanaka, Hiroshi; Kumagai, Jiro; Y 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 785 KB

144 UNILATERAL POSITIVE PROSTATE BIOPSY

144 UNILATERAL POSITIVE PROSTATE BIOPSY PREDICTS MORE FAVORABLE PATHOLOGIC AND ONCOLOGIC OUTCOMES IN SELECTION OF CANDIDATES FOR FOCAL THERAPY

✍ Finkelstein, Julia B.; Berkman, Douglas S.; Lepor, Herbert; Taneja, Samir S. 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 93 KB

P103 Determination of susceptibility sin

P103 Determination of susceptibility single nucleotide polymorphisms does not significantly improve the predictive value of a prostate cancer risk calculator in selecting men for prostate biopsy

✍ Butoescu, V.; Ambroise, J.; Stainier, A.; De Kairelle, A.F.; Gala, J.L.; Tombal, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB